Functional polymorphisms and haplotypes in the promoter of the MMP2 gene are associated with risk of nasopharyngeal carcinoma
- PMID: 17607721
- DOI: 10.1002/humu.20570
Functional polymorphisms and haplotypes in the promoter of the MMP2 gene are associated with risk of nasopharyngeal carcinoma
Abstract
Matrix metalloproteinases (MMPs) play important roles in cancer initiation and development. Several polymorphisms in the promoters of a number of MMP genes, which can affect the respective MMP production in an allele-specific manner, have been well characterized. We examined whether these functional polymorphisms were related to the risk of nasopharyngeal carcinoma (NPC) in Chinese populations. Eight polymorphisms in the promoter of MMP1, MMP2, MMP3, MMP7, MMP9, MMP12, and MMP13 were genotyped in two independent case-control populations; one is from Guangxi province (593 patients with NPC and 480 controls), and the other is from Guangdong province (239 patients and 286 controls). We observed significantly increased susceptibility to NPC for the MMP2 -1306CC (rs243865:C>T) (odds ratio [OR] = 2.01, 95% confidence interval [CI] = 1.30-3.10) and -735CC (rs2285053:C>T) (OR = 1.56, 95% CI = 1.17-2.09) genotype carriers compared with noncarriers in the Guangxi population. This association was confirmed in the Guangdong population (for -1306CC: OR = 2.19, 95% CI = 1.21-3.96; for -735CC: OR = 1.60, 95% CI = 1.13-2.28). The C(-1306)-C(-735) haplotype was also significantly associated with increased susceptibility to NPC in both the Guangxi (OR = 1.64, 95% CI = 1.35-1.99) and Guangdong population (OR = 1.68, 95% CI = 1.29-2.19). Furthermore, stratified analysis indicated that the increased susceptibility to NPC related to the -1306CC and -735CC genotype and the C(-1306)-C(-735) haplotype was more pronounced in heavier smokers. Our findings suggest that the genetic polymorphisms or haplotype in the MMP2 promoter may play a role in mediating the susceptibility to NPC in Chinese populations.
2007 Wiley-Liss, Inc.
Similar articles
-
Functional haplotypes in the promoter of matrix metalloproteinase-2 and lung cancer susceptibility.Carcinogenesis. 2005 Jun;26(6):1117-21. doi: 10.1093/carcin/bgi057. Epub 2005 Feb 24. Carcinogenesis. 2005. PMID: 15731163
-
Association of transforming growth factor-beta1 gene polymorphisms with genetic susceptibility to nasopharyngeal carcinoma.Clin Chim Acta. 2007 May 1;380(1-2):165-9. doi: 10.1016/j.cca.2007.02.008. Epub 2007 Feb 15. Clin Chim Acta. 2007. PMID: 17368597
-
Functional haplotypes in the promoter of matrix metalloproteinase-2 predict risk of the occurrence and metastasis of esophageal cancer.Cancer Res. 2004 Oct 15;64(20):7622-8. doi: 10.1158/0008-5472.CAN-04-1521. Cancer Res. 2004. PMID: 15492291
-
Influence of matrix metalloproteinase genotype on cardiovascular disease susceptibility and outcome.Cardiovasc Res. 2006 Feb 15;69(3):636-45. doi: 10.1016/j.cardiores.2005.07.015. Epub 2005 Aug 24. Cardiovasc Res. 2006. PMID: 16122719 Review.
-
Matrix metalloproteinase (MMP) -2, -7 and -9 promoter polymorphisms in colorectal cancer in ethnic Kashmiri population - A case-control study and a mini review.Gene. 2016 Sep 1;589(1):81-89. doi: 10.1016/j.gene.2016.05.028. Epub 2016 May 21. Gene. 2016. PMID: 27222481 Review.
Cited by
-
TSPAN1 inhibits metastasis of nasopharyngeal carcinoma via suppressing NF-kB signaling.Cancer Gene Ther. 2024 Mar;31(3):454-463. doi: 10.1038/s41417-023-00716-w. Epub 2023 Dec 22. Cancer Gene Ther. 2024. PMID: 38135697
-
Meta-analysis of MMP2, MMP3, and MMP9 promoter polymorphisms and head and neck cancer risk.PLoS One. 2013 Apr 24;8(4):e62023. doi: 10.1371/journal.pone.0062023. Print 2013. PLoS One. 2013. PMID: 23637955 Free PMC article.
-
Functional polymorphism -31C/G in the promoter of BIRC5 gene and risk of nasopharyngeal carcinoma among chinese.PLoS One. 2011 Feb 3;6(2):e16748. doi: 10.1371/journal.pone.0016748. PLoS One. 2011. PMID: 21304814 Free PMC article.
-
The association between gene polymorphisms and risk of nasopharyngeal carcinoma.Med Oncol. 2015 Jan;32(1):398. doi: 10.1007/s12032-014-0398-5. Epub 2014 Dec 7. Med Oncol. 2015. PMID: 25481674
-
Functional polymorphisms of matrix metalloproteinase-9 and survival in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy.Med Oncol. 2013 Dec;30(4):685. doi: 10.1007/s12032-013-0685-6. Epub 2013 Aug 18. Med Oncol. 2013. PMID: 23955812 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous